跳至主要内容
临床试验/EUCTR2013-004666-34-HU
EUCTR2013-004666-34-HU进行中(未招募)不适用

Reversal of vecuronium induced residual neuromuscular block usingsugammadex: a prospective, dobule-blind, randomized, controlled,dosefinding study

niversity of Debrecen, Medical and Health Science Center, Department of Anaesthesiology and Intensive Therapy0 个研究点开始时间: 2014年1月29日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1. Pateint aged 18-65 undergoing general surgery in neuromuscular
  • 2. ASA (American Society of Anesthesiology) physical status score 1-3
  • 3. BMI (Body-Mass Index) 18,5-25
  • 4. duration of operation over 50 minutes
  • 5. need for intratracheal intubation
  • 6. supine position, at least one arm accessible.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 60
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1. diseases influencing neuromuscular function (myopathies, significant
  • renal or hepatic insufficiency)
  • 2. drugs influencing neuromuscular function (magnesium,
  • aminoglycosides)
  • 3. gravidity,lactation
  • 4. urgent surgery
  • 5. chronic obstructive pulmonary disease
  • 6. bronchial asthma
  • 7. glaucoma
  • 8. difficult airway management possible

研究者

发起方
niversity of Debrecen, Medical and Health Science Center, Department of Anaesthesiology and Intensive Therapy

相似试验